Faster Answers, Smarter Decisions: A New Standard for Cognitive Health
Evaluating memory, attention, language, and social cognition still relies on subjective tools and in-person assessments. This results in long waitlists, inconsistent decisions, and limited ways to track progress, especially for families navigating cognitive challenges. Clinicians and researchers also lack reliable metrics to measure whether interventions are working.
NeuroCog.ai is a next-generation Software as a Medical Device (SaMD) platform that delivers precise cognitive assessments through real-time gaze tracking and explainable AI. All processing runs locally on pre-configured, centrally managed devices, with no video uploads or cloud dependencies.
The platform is modular and built for clinical and research use, combining AI-powered tools with rigorously standardized cognitive tests.
Platform Components
- Gaze tracking engine: ultra-precise and privacy-preserving, running fully on-device via Edge AI with no video uploads. Supports multi-camera input, real-time processing, and deterministic inference. Deployed on validated, centrally managed devices to ensure reproducible performance.
- Cognitive test library: spans all neurocognitive domains and subdomains defined in the DSM-5 by the American Psychiatric Association. Built for longitudinal tracking and consistent administration across populations.
- Smart EMR interface: agentic AI liaison for note-taking within Electronic Medical Records, structuring clinical data to support analytics, decision-making, and regulatory compliance.
- Explainable analytics engine: provides interpretable outputs and tracks cognitive function over time, enabling clinicians and researchers to monitor change and quantify outcomes.
- Treatment Co-Pilot: predicts the likelihood of treatment success using real-world evidence and contextual task performance.
NeuroCog gives clinicians more confidence, families faster answers, and researchers the metrics they need. By standardizing how cognition is assessed and monitored, it reduces costs, improves access to care, and raises the bar for evidence-based treatment.
Behind the Screens and Ahead of the Curve
What they’ve done
Since launching in 2023, NeuroCog.ai has moved decisively from concept to deployment readiness. The team has conducted over 60 clinician interviews, completed more than 50 external test sessions, and released a working MVP in late 2024. Incorporation and IP protections were finalized early, alongside the creation of a stakeholder-ready data room and a scalable licensing framework. Through Innovation UBC and Founders University in San Francisco, they refined their go-to-market strategy while preparing for international deployment. Technical infrastructure now meets SOC 2 and ISO 27001 standards. After showcasing at Web Summit Vancouver, the team is preparing a web presence that speaks to both families and clinicians, aiming to build trust, accelerate referrals, and advance the conversation around next-generation cognitive health tools.
Why NVBC
NeuroCog joined the 2025 competition to refine its investor-facing strategy, pressure-test positioning, and align messaging ahead of pilot deployments. As a BC-based medtech company operating at the intersection of AI, cognitive science, and patient privacy, NVBC provides an ideal platform to benchmark readiness for Health Canada trials and engage a growing ecosystem of founders, funders, and partners committed to deep tech with long-term clinical impact.
Up Next
Over the next 6 to 12 months, NeuroCog will initiate pilot studies with early adopter clinics and academic partners to generate real-world data under a pre-market regulatory framework. Its gaze-tracking model will continue evolving within a versioned, traceable system built for FDA and Health Canada compliance. Commercial efforts will focus on clinician onboarding, pricing strategies, and regional distribution channels.
NeuroCog’s licensing model includes pre-configured devices leased as part of an annual subscription, enabling clinics to deliver reimbursable assessments with minimal setup. Clinicians are compensated for interpreting results, while NeuroCog earns by automating the administration. Both components are designed to align with reimbursement frameworks and scale efficiently across care settings.
Built for Impact, Engineered for Trust
NeuroCog.ai was designed for long-term value, not short-term headlines. From the outset, the team prioritized reproducibility, privacy, and regulatory alignment to build a platform capable of transforming how cognitive function is measured in real-world settings. Founder and physician Walter Sena made a strategic decision to protect intellectual property and develop an auditable, deployment-ready system before seeking academic publication or early media attention.
This deliberate approach has created a differentiated position in the digital health landscape. NeuroCog.ai now moves forward with a validated architecture, a privacy-first machine learning stack, and growing clinical interest from partners who value both precision and explainability. What the team is building is not just a product; it’s infrastructure for the next generation of cognitive health.
Meet the Team
Walter Sena, MD MSc
Founder, CEO, and Chief Medical Information Officer
Fun Fact: Walter rocked dreadlocks while backpacking around the world for two years between pre-med and med school.
Company Cheatsheet
City: Squamish
Founded: October 2, 2023
Sector: Medtech
